Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookGuidelines for Antiretroviral Therapy in Ghana (MOH-GHS; 2002; 40 pages)
View the documentACKNOWLEDGEMENTS
View the documentFOREWORD
View the documentLIST OF ACRONYMS
Open this folder and view contentsCHAPTER 1
close this folderCHAPTER 2
View the documentAntiretroviral therapy
View the documentIntroduction of ART
View the documentStrategies to Achieve effective ART
View the documentInitiation
View the documentInitiation Criteria
View the documentExclusion Criteria
View the documentInterruption of Therapy
View the documentCriteria for Changing Therapy
View the documentRecommended ART Regimen
View the documentDrug Interactions
View the documentRecommendations for Antiretroviral Therapy in Patients with Tuberculosis
View the documentOther interactions
View the documentManagement of Opportunistic Infections
View the documentClinical Monitoring
View the documentLaboratory Monitoring
View the documentPost Exposure Prophylaxis for Health Care Workers
Open this folder and view contentsCHAPTER 3
Open this folder and view contentsCHAPTER 4
View the documentAPPENDIX 1
View the documentAPPENDIX 2
View the documentAPPENDIX 3
View the documentAPPENDIX 4
 

Post Exposure Prophylaxis for Health Care Workers

Post Exposure prophylaxis may reduce the likelihood of HIV infection after high-risk exposure. PEP may either prevent the establishment of infection or prevent new infection while allowing clearance of already infected cells. PEP is particularly effective within 24 to 48 hours of exposure.

1. All infection prevention programmes should be in place and health workers should follow procedures at all times to prevent exposure. In the event of possible exposure to HIV the following actions should be taken immediately.

2. All health workers accessing the post exposure prophylaxis package should receive counselling from a trained counsellor throughout the period and thereafter if necessary.

3. Treatment of exposure site: The wound site should be cleaned with soap and water/or in the case of mucous membranes flushed with water.

4. Timing of post-HIV exposure prophylaxis initiation

If therapy is necessary it should be initiated promptly, preferably 1 to 2 hours post exposure.

5. Assessment of exposure risk
Low risk exposure is

• Exposure to a small volume of blood or blood contaminated fluids from asymptomatics HIV-positive patients with low viral load

• An injury with a solid needle

• Any superficial injury or mucocutaneous exposure

High-risk exposure is:

• Exposure to a large volume of blood or potentially infectious fluids

• Exposure to blood or blood contaminated fluids from a patient with a high viral titre. i.e. in the AIDS phase or early sercoconversion phase of HIV

• Injury with a hollow bore needle

• Deep and extensive injury

• Drug resistance in source patient


6. Post -HIV exposure prophylaxis

Low risk:

Lamivudine 150 mg 12 hourly x 28 days
Zidovudine 200 mg 8 hourly x 28 days


High risk:

Zidovudine 200 mg 8-hourly x 28 days
Lamivudine 150 mg 12 hourly x 28 days
Indinavir 800 mg 8 hourly x 28 days
Nelfinavir 750 mg tid or 1250 mg bid x 28 days


7. Recommended drug toxicity and HIV serology testing after exposure

Baseline tests:

Full blood count
Liver and renal function tests, Hepatitis Surface Antigen
HIV serology/(PCR if available)

Two weeks:
Full blood count
Liver and renal function tests
Six weeks:
HIV serology
Three months:
HIV serology
Six months:
HIV serology

to previous sectionto next section

Please provide your feedback English  |  French